Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 80.30
-0.20 (-0.25%)
Nov 13, 2026, 1:30 PM CST
Syngen Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,048 | 2,136 | 2,014 | 1,837 | 1,931 | 1,471 |
Revenue Growth | -3.92% | 6.10% | 9.60% | -4.84% | 31.22% | 12.19% |
Gross Profit Gross Profit Growth | 635.67 | 723.59 | 723.94 | 643.92 | 688.15 | 528.34 |
Operating Income Operating Income Growth | 248.87 | 326.98 | 303.3 | 302.86 | 362.38 | 281.48 |
Net Income Net Income Growth | 204.72 | 271.59 | 240.21 | 274.83 | 321.24 | 237.77 |
Earnings Per Share EPS Growth | 7.54 | 10.01 | 8.85 | 10.13 | 11.84 | 8.76 |
EPS Growth | -29.97% | 13.11% | -12.64% | -14.44% | 35.16% | 10.33% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 2,021 | 1,870 | 1,699 | 1,770 | 1,298 |
Others Others Growth | 115.7 | 144.05 | 112.86 | 88.54 | 76.07 |
Total Total Growth | 2,136 | 2,014 | 1,837 | 1,931 | 1,471 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 322.49 | 275.47 | 341.93 | 366.89 | 246.05 | 314.8 |
Total Debt Total Debt Growth | 228.61 | 225.19 | 397.93 | 538.49 | 600.78 | 236.08 |
Net Cash (Debt) Net Cash Growth | 93.88 | 50.27 | -56 | -171.6 | -354.73 | 78.72 |
Net Cash Growth | - | - | - | - | - | -54.53% |
Net Cash Per Share Net Cash Per Share Growth | 3.46 | 1.85 | -2.06 | -6.33 | -13.07 | 2.90 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 319.82 | 319.48 | 348.04 | 415.13 | 277.48 | 336.5 |
Capital Expenditures CapEx Growth | -80.34 | -63.56 | -60.21 | -91.9 | -584.27 | -61.67 |
Free Cash Flow Free Cash Flow Growth | 239.48 | 255.92 | 287.83 | 323.23 | -306.79 | 274.83 |
Free Cash Flow Growth | -29.26% | -11.09% | -10.95% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.04% | 33.87% | 35.95% | 35.05% | 35.64% | 35.91% |
Operating Margin | 12.15% | 15.30% | 15.06% | 16.48% | 18.77% | 19.13% |
Pretax Margin | 12.46% | 15.67% | 14.88% | 18.17% | 20.53% | 20.08% |
Profit Margin | 10.00% | 12.71% | 11.93% | 14.96% | 16.64% | 16.16% |
FCF Margin | 11.69% | 11.98% | 14.29% | 17.59% | -15.89% | 18.68% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 5.000 | 5.000 | 5.000 | 4.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 25.00% | 14.29% |
Dividend Yield | 6.23% | 4.31% | 3.94% | 3.29% | 3.09% | 3.54% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.65 | 11.58 | 14.33 | 14.99 | 13.67 | 12.88 |
Forward PE | - | 14.12 | 14.12 | 13.63 | 14.48 | 12.56 |
P/FCF Ratio | 9.09 | 12.28 | 11.96 | 12.74 | - | 11.14 |
PS Ratio | 1.06 | 1.47 | 1.71 | 2.24 | 2.27 | 2.08 |